Cited by 2,782Antibiotic Resistance in BacteriaAntimicrobial Resistance in StaphylococcusBacterial Genetics and Biotechnology

The DOI matches its Crossref record; 110 of the 110 references it cites were found in a registry or an index; none of the 118 sources its claims cite is checked for support yet.

Mechanisms of Antibiotic Resistance

Open access
Munita, Jose M., Arias, Cesar A.·2016·Microbiology Spectrum

Abstract

Emergence of resistance among the most important bacterial pathogens is recognized as a major public health threat affecting humans worldwide. Multidrug-resistant organisms have not only emerged in the hospital environment but are now often identified in community settings, suggesting that reservoirs of antibiotic-resistant bacteria are present outside the hospital. The bacterial response to the antibiotic “attack” is the prime example of bacterial adaptation and the pinnacle of evolution. “Survival of the fittest” is a consequence of an immense genetic plasticity of bacterial pathogens that trigger specific responses that result in mutational adaptations, acquisition of genetic material, or alteration of gene expression producing resistance to virtually all antibiotics currently available in clinical practice. Therefore, understanding the biochemical and genetic basis of resistance is of paramount importance to design strategies to curtail the emergence and spread of resistance and to devise innovative therapeutic approaches against multidrug-resistant organisms. In this chapter, we will describe in detail the major mechanisms of antibiotic resistance encountered in clinical practice, providing specific examples in relevant bacterial pathogens.

Overview

AI snapshot

Written from the paper’s full text.

TL;DR

This review describes the major genetic and biochemical mechanisms by which bacteria resist antibiotics, including drug modification/destruction, reduced penetration and efflux, target alteration/protection/bypass, and global cell adaptations. It emphasizes acquired resistance through mutation and horizontal gene transfer and illustrates these mechanisms with clinically important examples such as β-lactamases, vancomycin resistance, daptomycin resistance, and linezolid resistance.

Key findings

  • Acquired resistance can arise from chromosomal mutations or acquisition of foreign DNA via horizontal gene transfer, including transformation, transduction, conjugation, mobile genetic elements, and integrons.
  • The paper classifies resistance mechanisms into four broad biochemical categories: (i) modification or destruction of the antibiotic, e.g., aminoglycoside-modifying enzymes, chloramphenicol acetyltransferases, and β-lactamases, with more than 1,000 β-lactamases described and 22 variants of *bla*KPC reported; (ii) decreased penetration or efflux, involving porins and five major efflux pump families (MFS, SMR, RND, ABC, MATE); (iii) target-site changes, including protection (TetM/TetO, Qnr), modification (*rpoB* for rifampin, *gyrA*/*parC* for fluoroquinolones, 23S rRNA/L3/L4 for linezolid, *erm* methylation), and replacement/bypass (*mecA*/PBP2a, *van* clusters, DHFR/DHPS overproduction); and (iv) global cell adaptations, such as LiaFSR, YycFG/WalKR, VraTSR, MprF, and *rpoB* changes in daptomycin and vancomycin-intermediate resistance.
  • The paper reports that the WHO named antibiotic resistance one of the three most important public health threats of the 21st century; MDR infections carry an economic burden estimated at over $20 billion per year in the US; the CDC conservatively estimates at least 23,000 deaths annually in the USA from antibiotic-resistant infections; and one report estimates around 300 million premature deaths by 2050 with up to $100 trillion in global economic loss.
  • Specific examples include MRSA via *mecA*-encoded PBP2a; enterococcal vancomycin resistance via nine described *van* clusters, with D-Ala-D-Lac replacement decreasing vancomycin affinity about 1,000-fold; hVISA/VISA isolates with vancomycin MICs of 4–8 μg/mL; and daptomycin resistance where a LiaF deletion increased the MIC from 1 to 4 μg/mL and abolished bactericidal activity, while 75% of daptomycin-susceptible *E. faecium* isolates with MICs between 3 and 4 μg/mL harbored LiaFSR mutations.

Methods

  • Narrative review chapter; no primary experimental design, sample, or statistical analysis is reported.
  • It synthesizes published literature and provides mechanistic examples from clinically relevant bacteria, without stating a systematic search strategy or inclusion criteria.
  • The main analysis is a conceptual classification of resistance mechanisms into genetic bases (mutation versus horizontal gene transfer) and four biochemical categories, illustrated with selected clinical examples.

Limitations

  • The paper does not state a limitations section.
  • Evident from the text: it is a narrative review rather than a systematic review, examples are selected for clinical relevance, and no primary data or quantitative synthesis are presented.
  • The paper also notes that some mechanisms remain incompletely understood, such as the exact mechanism by which LiaFSR mediates daptomycin resistance, the function of VanZ, and how *rpoB* mutations lead to reduced vancomycin and daptomycin susceptibility.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1128/microbiolspec.vmbf-0016-2015

Cites

110 of 110 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

0 of 118 cited sources checked · 0 supported · 0 flagged

Show all 86 claims

  • It may state two separate claims as one. 74
  • Probably not a substantial claim. 27
  • The quote only partly states this claim. 1
90 of 90
  • The paper relies on this without support.

    The environmental resistome is a prolific source for the acquisition of antibiotic resistance genes in clinically relevant bacteria.

    “As mentioned before, bacteria sharing the environment with these molecules harbor intrinsic genetic determinants of resistance and there is robust evidence suggesting that such “environmental resistome” is a prolific source for the acquisition of antibiotic resistance genes in clinically relevant bacteria.”
  • The paper relies on this without support.

    Most antimicrobial agents used in clinical practice are (or derive from) products naturally found in the environment, mostly soil.

    “Most antimicrobial agents used in clinical practice are (or derive from) products naturally found in the environment (mostly soil).”
  • The paper relies on this without support.

    The mechanism by which LiaFSR results in DAP-R is not fully understood.

    “The mechanism by which LiaFSR results in DAP-R is not fully understood.”
  • The paper relies on this without support.

    The specific mechanism through which LiaFSR orchestrates the cell-envelope response to stress is still a matter of active research.

    “Furthermore, the specific mechanism through which this system orchestrates the cell-envelope response to stress is still a matter of active research.”
  • The paper relies on this without support.

    The specific mechanisms that lead to the hVISA/VISA phenotype remain to be completely understood.

    “The specific mechanisms that lead to the hVISA/VISA phenotype remain to be completely understood.”
  • The paper relies on this without support.

    The mechanisms by which mutations in rpoB lead to reduced vancomycin and DAP susceptibility are unclear.

    “However, the mechanisms by which mutation if rpoB lead to reduced vancomycin and DAP susceptibility are unclear.”
  • The paper relies on this without support.

    The physiological role of LiaI and LiaH are not completely understood.

    “The physiological role of LiaI and LiaH are not completely understood.”
7 of 7

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Show all 110 references

Research works printed but not linked: 1

  1. The Review on Antimicrobial Resistance. 2014. Antimicrobial Resistance: Tackling a Crisis for the Future Health and Wealth of Nations. http://amr-review.org.

Cited by

Sorted by citations

Items 401–500 of 1,003

Metadata

Authors
Munita, J. M., & Arias, C. A.
Affiliations
  • Universidad del Desarrollo (CL)
  • Department of Internal Medicine, Division of Infectious Diseases, University of Texas Medical School at Houston, Houston, TX 77030
Venue
Microbiology Spectrum
Published
2016-03-25
Volume
4
Issue
2
ISSN
2165-0497 (ISSN-L)
OpenAlex
W2316777574
Cited by
2,782
References
110
Citations by year
2026: 213 · 2025: 315 · 2024: 359 · 2023: 386 · 2022: 379 · 2021: 374 · 2020: 337 · 2019: 265 · 2018: 124 · 2017: 17 · 2016: 6
FWCI
8.87
Type
journal article
Language
en
Open access
Locations
  • Microbiology Spectrum (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • Repositorio Institucional Universidad El Bosque (submittedVersion)
Funders
National Institute of Allergy and Infectious Diseases (R01AI093749)
Topics
  • Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
  • Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
Keywords
antibiotic resistance mechanisms, multidrug-resistant bacteria, bacterial adaptation, genome plasticity, bacterial evolution, community-acquired resistance, nosocomial infections, pathogenic bacteria, resistance gene acquisition, gene expression regulation
MeSH terms
Adaptation, Physiological, Anti-Bacterial Agents, Bacteria, Bacterial Infections, Drug Resistance, Microbial, Humans, Mutation, Drug Resistance, Multiple, Bacterial

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review